370 related articles for article (PubMed ID: 30633985)
1. Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.
Costa CD; Justo AA; Kobayashi PE; Story MM; Palmieri C; Laufer Amorim R; Fonseca-Alves CE
Int J Biochem Cell Biol; 2019 Mar; 108():21-28. PubMed ID: 30633985
[TBL] [Abstract][Full Text] [Related]
2. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
Hurt EM; Kawasaki BT; Klarmann GJ; Thomas SB; Farrar WL
Br J Cancer; 2008 Feb; 98(4):756-65. PubMed ID: 18268494
[TBL] [Abstract][Full Text] [Related]
3. Are CD44
Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
[TBL] [Abstract][Full Text] [Related]
4. Embryonic stem cells markers Oct4 and Nanog correlate with perineural invasion in human salivary gland mucoepidermoid carcinoma.
Destro Rodrigues MF; Sedassari BT; Esteves CM; de Andrade NP; Altemani A; de Sousa SC; Nunes FD
J Oral Pathol Med; 2017 Feb; 46(2):112-120. PubMed ID: 27131799
[TBL] [Abstract][Full Text] [Related]
5. Immunodetection of cells with a CD44+/CD24- phenotype in canine mammary neoplasms.
Magalhães GM; Terra EM; de Oliveira Vasconcelos R; de Barros Bandarra M; Moreira PR; Rosolem MC; Alessi AC
BMC Vet Res; 2013 Oct; 9():205. PubMed ID: 24119896
[TBL] [Abstract][Full Text] [Related]
6. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
7. Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer.
Aravindan S; Ramraj SK; Somasundaram ST; Herman TS; Aravindan N
Stem Cell Res Ther; 2015 Sep; 6(1):182. PubMed ID: 26395574
[TBL] [Abstract][Full Text] [Related]
8. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.
Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ
Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma.
Rodrigues MFSD; Xavier FCA; Andrade NP; Lopes C; Miguita Luiz L; Sedassari BT; Ibarra AMC; López RVM; Kliemann Schmerling C; Moyses RA; Tajara da Silva EE; Nunes FD
Head Neck; 2018 Aug; 40(8):1759-1773. PubMed ID: 29607565
[TBL] [Abstract][Full Text] [Related]
10. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
Guzmán-Ramírez N; Völler M; Wetterwald A; Germann M; Cross NA; Rentsch CA; Schalken J; Thalmann GN; Cecchini MG
Prostate; 2009 Nov; 69(15):1683-93. PubMed ID: 19644960
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of Oct-4 and Nestin in human breast cancers.
Liu C; Cao X; Zhang Y; Xu H; Zhang R; Wu Y; Lu P; Jin F
Mol Biol Rep; 2012 May; 39(5):5875-81. PubMed ID: 22207173
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the stemness potency of
Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
[TBL] [Abstract][Full Text] [Related]
14. SHBG is an important factor in stemness induction of cells by DHT in vitro and associated with poor clinical features of prostate carcinomas.
Ma Y; Liang D; Liu J; Wen JG; Servoll E; Waaler G; Sæter T; Axcrona K; Vlatkovic L; Axcrona U; Paus E; Yang Y; Zhang Z; Kvalheim G; Nesland JM; Suo Z
PLoS One; 2013; 8(7):e70558. PubMed ID: 23936228
[TBL] [Abstract][Full Text] [Related]
15. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
16. Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis.
Siddiqui Z; Srivastava AN; Sankhwar SN; Dalela D; Singh V; Zaidi N; Fatima N; Bano I; Anjum S
Br J Biomed Sci; 2020 Apr; 77(2):69-75. PubMed ID: 31718471
[No Abstract] [Full Text] [Related]
17. [Altered expressions of embryonic stem-related genes in pancreatic cancer stem cell].
Lu YH; Zhu H; Wang ZW; Fan XJ; Zhu SJ; Li XH; Wang Y; Lu JJ; Zhu MY
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3107-10. PubMed ID: 22340650
[TBL] [Abstract][Full Text] [Related]
18. Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.
Jaggupilli A; Elkord E
Clin Dev Immunol; 2012; 2012():708036. PubMed ID: 22693526
[TBL] [Abstract][Full Text] [Related]
19. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
